Daniel J. O'Connor
2013 - Advaxis
In 2013, Daniel J. O'Connor earned a total compensation of $460.1K as President and Chief Executive Officer at Advaxis.
Compensation breakdown
| Bonus | $103,042 |
|---|---|
| Option Awards | $104,040 |
| Salary | $209,423 |
| Stock Awards | $43,625 |
| Total | $460,130 |
O'Connor received $209.4K in salary, accounting for 46% of the total pay in 2013.
O'Connor also received $103K in bonus, $104K in option awards and $43.6K in stock awards.
Rankings
In 2013, Daniel J. O'Connor's compensation ranked 9,622nd out of 12,286 executives tracked by ExecPay. In other words, O'Connor earned more than 21.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,622 out of 12,286 | 22nd |
Division Manufacturing | 3,560 out of 4,612 | 23rd |
Major group Chemicals And Allied Products | 1,127 out of 1,466 | 23rd |
Industry group Drugs | 874 out of 1,160 | 25th |
Industry Pharmaceutical Preparations | 683 out of 890 | 23rd |
Source: SEC filing on February 27, 2014.
O'Connor's colleagues
We found three more compensation records of executives who worked with Daniel J. O'Connor at Advaxis in 2013.
News
OncoSec Medical CEO Daniel O'Connor's 2021 pay jumps 122% to $3M
May 31, 2022
OncoSec Medical CEO Daniel O'Connor's 2020 pay rises 15% to $1.4M
March 18, 2021
OncoSec Medical CEO Daniel O'Connor's 2019 pay falls 72% to $1.2M
April 30, 2020
OncoSec Medical CEO Daniel O'Connor's 2018 pay falls 39% to $4.2M
November 8, 2018